Drug Shortage Report for DUAVIVE

Last updated on 2020-11-17 History
Report ID 114978
Drug Identification Number 02432854
Brand name DUAVIVE
Common or Proper name Duavive
Company Name PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) CONJUGATED ESTROGENS BAZEDOXIFENE
Strength(s) 0.45MG 20MG
Dosage form(s) TABLET (IMMEDIATE AND EXTENDED RELEASE)
Route of administration ORAL ORAL
Packaging size 28's blister
ATC code G03CC
ATC description ESTROGENS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-05-11
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2020-11-17
Company comments A more specific re-supply timeline will be provided as information becomes available.
Health Canada comments
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v13 2020-11-17 French Compare
v12 2020-11-17 English Compare
v11 2020-09-08 French Compare
v10 2020-09-08 English Compare
v9 2020-09-08 English Compare
v8 2020-08-21 French Compare
v7 2020-08-21 English Compare
v6 2020-07-23 French Compare
v5 2020-07-23 English Compare
v4 2020-07-03 French Compare
v3 2020-07-03 English Compare
v2 2020-05-13 French Compare
v1 2020-05-13 English Compare